Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.93B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$297M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$219M |
| 4 |
Johnson & Johnson
JNJ
|
+$210M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.2B |
| 2 |
Bausch Health
BHC
|
+$484M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$333M |
| 4 |
AT&T
T
|
+$279M |
| 5 |
LO
LORILLARD INC COM STK
LO
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.63% |
| 2 | Technology | 4.94% |
| 3 | Financials | 3.76% |
| 4 | Energy | 3.19% |
| 5 | Industrials | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5026
CALL
Madison Square Garden
MSGS
$9.42B
| $50K | ﹤0.01% |
841
-16,684
| -95% | -$1M |
|
5027
Enpro
NPO
$6.94B
| $50K | ﹤0.01% |
878
-9,929
| -92% | -$625K |
|
5028
CALL
Teekay
TK
$946M
| $50K | ﹤0.01% |
1,200
-9,200
| -88% | -$435K |
|
5029
CALL
Vanda Pharmaceuticals
VNDA
$306M
| $50K | ﹤0.01% |
4,200
-134,400
| -97% | -$1.45M |
|
5030
PUT
Wendy's
WEN
$1.52B
| $50K | ﹤0.01% |
4,500
-2,600
| -37% | -$28.7K |
|
|
VAR
5031
CALL
DELISTED
Varian Medical Systems, Inc.
VAR
| $50K | ﹤0.01% |
684
+570
| +500% | +$44.6K |
|
|
IPF
5032
DELISTED
SPDR S&P International Financial Sector
IPF
| $50K | ﹤0.01% |
2,375
| – | – |
|
|
PMCS
5033
PUT
DELISTED
P M C SIERRA INC
PMCS
| $50K | ﹤0.01% |
6,200
+2,100
| +51% | +$18.8K |
|
|
ORBC
5034
DELISTED
ORBCOMM, Inc.
ORBC
| $50K | ﹤0.01% |
8,344
+6,690
| +404% | +$43.5K |
|
|
DCOM
5035
DELISTED
Dime Community Bancshares
DCOM
| $50K | ﹤0.01% |
3,096
+2,112
| +215% | +$34.7K |
|
5036
PUT
Church & Dwight Co
CHD
$24.6B
| $49K | ﹤0.01% |
1,200
-3,200
| -73% | -$134K |
|
5037
Entegris
ENTG
$22.2B
| $49K | ﹤0.01% |
3,503
-6,216
| -64% | -$87.2K |
|
|
FISV
5038
PUT
Fiserv Inc
FISV
$28.9B
| $49K | ﹤0.01% |
1,200
-5,200
| -81% | -$209K |
|
5039
PUT
Cedar Fair
FUN
$1.92B
| $49K | ﹤0.01% |
900
+700
| +350% | +$40.1K |
|
5040
iShares Europe ETF
IEV
$1.69B
| $49K | ﹤0.01% |
1,133
| – | – |
|
5041
Lands' End
LE
$393M
| $49K | ﹤0.01% |
2,039
+1,051
| +106% | +$30.2K |
|
5042
Grand Canyon Education
LOPE
$3.92B
| $49K | ﹤0.01% |
1,152
-15,177
| -93% | -$657K |
|
5043
Portland General Electric
POR
$5.79B
| $49K | ﹤0.01% |
1,499
-18,926
| -93% | -$664K |
|
5044
Stagwell
STGW
$2.16B
| $49K | ﹤0.01% |
2,570
-7,233
| -74% | -$165K |
|
|
CONE
5045
DELISTED
CyrusOne Inc Common Stock
CONE
| $49K | ﹤0.01% |
1,695
-9,258
| -85% | -$289K |
|
|
MBFI
5046
DELISTED
MB Financial Corp
MBFI
| $49K | ﹤0.01% |
1,439
-552
| -28% | -$17.7K |
|
|
HIBB
5047
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $49K | ﹤0.01% |
1,067
-3,862
| -78% | -$184K |
|
|
GCI
5048
PUT
DELISTED
Gannett Co., Inc
GCI
| $49K | ﹤0.01% |
+3,750
| New | +$53.5K |
|
5049
PUT
Angi Inc
ANGI
$194M
| $48K | ﹤0.01% |
800
+20
| +3% | +$1.23K |
|
5050
Apogee Enterprises
APOG
$897M
| $48K | ﹤0.01% |
915
+42
| +5% | +$2.27K |
|
Similar funds
Barclays's Q2 2015 Portfolio in Review
As of Q2 2015, Barclays held 7,557 positions worth $89.1B, up 2.7% from $86.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays's Q2 2015 filing shows 425 new, 2,570 increased, 3,770 reduced and 450 closed positions. Its largest new stake was Element Solutions: 801,973 shares worth $20M. The largest sale was iPath ETNs Linked to the MSCI India Total Return Index, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 7.6% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2015 buy was Element Solutions: 801,973 shares worth $20M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.93B increase.
- Barclays's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $484M.
- Barclays fully exited iPath ETNs Linked to the MSCI India Total Return Index in Q2 2015, selling an estimated $1.2B.
- Barclays's ten largest holdings make up 31% of its $89.1B portfolio in Q2 2015.
- Barclays opened 425 new positions and closed 450 in Q2 2015.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $89.1B.
Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.